login
Password reminder
Cardiac Rhythm News
Contact the editor Visit Cardiac Rhythm News Twitter feed Visit Cardiac Rhythm News Facebook page
 

One in 1,000 risk of death from catheter ablation for AF


Tuesday, 05 May 2009 14:23

One in every 1,000 catheter ablations of atrial fibrillation results in the death of the patient, according to a study published in the 12 May 2009 issue of the Journal of the American College of Cardiology.


The authors of the article "Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial Fibrillation" wrote that "knowledge of possible precipitating causes is key to operators and needs to be considered during decision making with patients."


The purpose of the study, led by Dr Ricardo Cappato, Arrhythmia and Electrophysiology Center, Policlinico San Donato, Milan, Italy, was to provide a systematic multicentre survey on the incidence and causes of death occurring in the setting of or as a consequence of catheter ablation of atrial fibrillation.


Using a retrospective case series, data relevant to the incidence and cause of intra- and post-procedural death occurring in patients undergoing ablation of atrial fibrillation between 1995 and 2006 were collected from 162 of 546 identified centres worldwide.


Thirty-two deaths (.98 per 1,000 patients) were reported during 45,115 procedures in 32,569 patients. Causes of deaths included tamponade in eight patients (one later than 30 days), stroke in five patients (two later than 30 days), atrioesophageal fistula in five patients, and massive pneumonia in two patients. Myocardial infarction, intractable torsades de pointes, septicemia, sudden respiratory arrest, extrapericardial pulmonary vein perforation, occlusion of both lateral pulmonary veins, hemothorax, and anaphylaxis were reported to be responsible for one death each, while asphyxia from tracheal compression secondary to subclavian hematoma, intracranial bleeding, acute respiratory distress syndrome, and esophageal perforation from an intraoperative transesophageal echocardiographic probe were causes of one late death each.




Add New Comment

Most popular


Abbott to acquire St Jude Medical
Tuesday, 03 May 2016
Abbott is set to acquire St Jude Medical, expanding its portfolio to cover cardiovascular markets such as atrial fibrillation, structural heart and heart failure as well as neuromodulation. The ... Abbott to acquire St Jude Medical

First leadless pacemaker approved in the USA
Wednesday, 06 Apr 2016
Medtronic has announced it has received US Food and Drug Administration (FDA) approval for its Micra Transcatheter Pacing System (TPS). The leadless device, which is 93% smaller than conventional ... First leadless pacemaker approved in the USA

St Jude Medical MultiPoint Pacing Technology could achieve 87% patient response rate according to clinical trial
Thursday, 05 May 2016
Results of St Jude Medical’s MultiPoint Pacing investigational device exemption clinical study have been presented during a late-breaking clinical trial session at the Heart Rhythm Society’s (HR... St Jude Medical MultiPoint Pacing Technology could achieve 87% patient response rate according to clinical trial

Features


Importance of obstructive sleep apnoea in EP
Thursday, 26 May 2016
Syed Rafay A Sabzwari and Dhanunjaya Lakkireddy (Kansas City, USA) review the importance of obstructive sleep apnoea (OSA) in electrophysiology and cardiology at large, as a secondary impact to an ... Importance of obstructive sleep apnoea in EP

Ventricular tachycardia ablation in Chagas disease
Friday, 13 May 2016
Guilherme Fenelon (Sao Paulo, Brazil) overviews the role of ablation of ventricular tachycardia in Chagas disease. He says: catheter ablation in Chagas disease remains a “challenging procedure,” ... Ventricular tachycardia ablation in Chagas disease

Profiles


George Van Hare
Wednesday, 04 May 2016
George Van Hare (The Louis Larrick Ward professor of Pediatrics and director, Division of Pediatric ... George Van Hare

Jonathan Kalman
Monday, 18 Jan 2016
A leading heart rhythm expert in Australia, Jonathan M Kalman directs both clinical and research ... Jonathan Kalman

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions